The conceptual 'ARMC' wearable has been created as an artificial pancreas that can be worn on the arm to help diabetes patients manage their heath in a more streamlined manner.
Connecting to an accompanying app, the device works by continuously calculating the amount of insulin that is required by the wearer and administering it accordingly. This eliminates the need to manually inject medication to keep the patient feeling less restricted by their health when at work or a social gathering.
The conceptual 'ARMC' wearable is the design work of JEON Kiseop and Juhyeong LEE, and comes as a response to the increase need for innovation when it comes to insulin injection and diabetes management. As consumers become more comfortable with wearable technology, we could see more solutions being designed to take advantage of this.
Image Credit: Tuvie
What's Driving This Trend
- Artificial Pancreas Wearables
- Opportunity to create wearables with AI technology that can replace manual insulin injections and make life easier for diabetes patients.
- Smart Insulin Delivery Devices
- Development of insulin delivery wearables that can calculate and administer the correct amount of insulin continuously and reduce the burden for diabetes patients.
- Wearable Technology for Health Management
- Trend towards wearable technology that can monitor and manage health conditions, providing opportunities for innovation in this field.
Who This Affects Most
- Healthcare
- Opportunity for healthcare companies to invest in and develop wearables that can improve diabetes management and other health conditions using technology.
- Wearable Technology
- Wearable tech companies can create new products or partnerships that can integrate AI and other technologies with diabetes management and other health applications.
- Pharmaceuticals
- Developing wearables to improve insulin delivery or other medication delivery systems can create opportunities for pharmaceutical companies to expand their product portfolio.
